This technology tackles poor regeneration at the neuromuscular junction in the peripheral nervous system by developing an implantable electrical stimulation platform with two main technological advantages. Firstly, it features an externally controller for adjustable stimulation parameters. Secondly, it includes validated platforms that utilize miniaturized implanted electrodes to deliver distal electrical stimulation, further promoting regeneration at the damaged neuromuscular junctions.

Our team dedicate to develop an implantable bioelectronic platform, with integrating of cutting-edge biotechnology. We focus on miniaturized implantable device for remote electrical stimulation, aiming to enhance neuromuscular system regenerationsubsequent functional recovery. We further optimize the stimulation parametersvalidate its feasibilitybiosafety of current prototype through animal experiments. Currently, we are conducting efficacy verificationpreclinical testing.

Our invention targets neuromuscular system regeneration. Collaborating with Taiwan＇s top implantable medical device manufacturers, we develop an innovative implantable bioelectronic platform. Our objectives include research, testing, mass production,validation, with leveraging robust electronic medical equipment supply chain in Taiwan. This positions us to enter the neurorepairregeneration industry, primarily focusing on the Asia-PacificNorth American markets.